MedPath
TGA Approval

REMSIMA infliximab 120 mg solution for injection prefilled syringe (326143)

326143

REMSIMA infliximab 120 mg solution for injection prefilled syringe

Celltrion Healthcare Australia Pty Ltd

November 12, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7b89645ed2c9aab069aad5e4424283b4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5add6681ea597f9a0f5e5d4f17833920.pdf

Active Ingredients

Infliximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.